© 2005 Oxford University Press
ARTICLE |
Familial Risk of Cancer Shortly After Diagnosis of the First Familial Tumor
Affiliations of authors: Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany (JLB, KH); Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden (KH)
Correspondence to: J. Lorenzo Bermejo, PhD, Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany (e-mail: J.Lorenzo{at}dkfz.de).
Background: The diagnosis of the first cancer in a family may lead to the medical examination of the patient's relatives and the subsequent identification of additional familial cancers. If detection bias is present, familial risks could be overestimated soon after first diagnosis. Methods: We followed 1 677 722 offspring/siblings of 846 448 probands from the year of diagnosis of the first familial tumor to the diagnosis of first cancer, death, emigration, or December 31, 2002, using the Swedish Family Cancer Database. The risks of cancer among the offspring and siblings of patients with melanoma and cancers of the breast, prostate, colorectum, cervix, and lung were compared with those in the general population. Relative risks (RRs) were determined using Poisson regression, according to the time after first diagnosis. All statistical tests were two-sided. Results: Daughters of women with breast cancer had a statistically significantly higher relative risk of in situ breast cancer during the year of the mother's diagnosis than they did 5 or more years later (RR = 4.78, 95% confidence interval [CI] = 2.16 to 10.6, 26.6 cases per 100 000, versus RR = 1.97, 95% CI = 1.65 to 2.37, 27.2 cases per 100 000; P = .033). Daughters diagnosed the same year as their mothers were younger and were diagnosed earlier in the calendar year than daughters of women diagnosed 5 or more years after their mothers. Similarly, the risk of invasive melanoma among the offspring of individuals with invasive melanoma was higher during the year of the parent's diagnosis than it was 5 or more years afterward (RR = 8.27, 95% CI = 3.82 to 17.9, 57.0 cases per 100 000, versus RR = 3.18, 95% CI = 2.55 to 3.97, 37.6 cases per 100 000; P = .019). Sibling risks of in situ breast cancer, in situ cervical cancer, and invasive prostate cancer also decreased with time after diagnosis of the first familial tumor. Conclusions: Increased surveillance may result in the earlier detection of asymptomatic familial cancers, i.e., in detection bias. The possibility of overestimated familial risks of cancer shortly after diagnosis of the first familial tumor should be considered before a patient's clinical and genetic counseling is implemented.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- Risks of Cancer and Families
- Marvin Zelen
J Natl Cancer Inst 2005 97: 1556-1557.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  P. Rebora, K. Czene, and M. Reilly Timing of Familial Breast Cancer in Sisters J Natl Cancer Inst, May 21, 2008; 100(10): 721 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, J. Ji, A. Forsti, J. Sundquist, and P. Lenner Concordance of Survival in Family Members With Prostate Cancer J. Clin. Oncol., April 1, 2008; 26(10): 1705 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, J. Sundquist, and J. Lorenzo Bermejo Familial Risks for Cancer as the Basis for Evidence-Based Clinical Referral and Counseling Oncologist, March 1, 2008; 13(3): 239 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, J. Sundquist, and J. L. Bermejo How common is familial cancer? Ann. Onc., January 1, 2008; 19(1): 163 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, J. Ji, and A. Forsti Risks for Familial and Contralateral Breast Cancer Interact Multiplicatively and Cause a High Risk Cancer Res., February 1, 2007; 67(3): 868 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki and B. Chen Familial risks for cervical tumors in full and half siblings: etiologic apportioning. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1413 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Bermejo and K. Hemminki Re: Risks of cancer and families. J Natl Cancer Inst, April 19, 2006; 98(8): 563 - 564. [Full Text] [PDF]
|
|
|
|
|
|
M. Zelen Risks of Cancer and Families J Natl Cancer Inst, November 2, 2005; 97(21): 1556 - 1557. [Full Text] [PDF]
|
|